Health Care & Life Sciences » Biotechnology | Charles River Laboratories International Inc.

Charles River Laboratories International Inc.

Charles River Laboratories International Inc.
Stock Exchange New York Stock Exchange
EPS
$4.65
Market Cap
$6.94 B
Shares Outstanding
48.75 M
Public Float
47.32 M

Profile

Address
251 Ballardvale Street
Wilmington Massachusetts 01887
United States
Employees -
Website http://www.criver.com
Updated 07/08/2019
Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following business segments: Research Models & Services, Discovery & Safety Assessment, and Manufacturing Support. The Research Models & Services segment comprises of the production and sale of research models, and also offers services designed to support its client's use of research models in screening non-clinical drug candidates.

Financials

View All
Created with Highcharts 5.0.14Charles River Laboratories International Inc.Net Income. Fiscal year is January-December. All values USD Millions.104104128128150150154154123123225225201320142015201620172018050100150200250
Created with Highcharts 5.0.14Charles River Laboratories International Inc.Sales/Revenue. Fiscal year is January-December. All values USD Millions.1 1661 1661 2981 2981 3631 3631 6811 6811 8581 8582 2662 26620132014201520162017201805001000150020002500

James C. Foster
Chairman, President & Chief Executive Officer
Jean-Paul Mangeolle
Independent Director